Apple must face claims it bars outside heart-rate apps from Apple Watch
- U.S. judge
Send a link to a friend
[March 22, 2022]
By Jonathan Stempel
(Reuters) - A federal judge on Monday said
Apple Inc must face a Silicon Valley company's claims it illegally
monopolized the U.S. market for heart rate monitoring apps for its Apple
Watch.
U.S. District Judge Jeffrey White said AliveCor Inc, whose SmartRhythm
app alerts users to irregular heartbeats, could try to prove that Apple
violated federal antitrust law based on its alleged "complete control"
over the market for such apps.
"AliveCor alleges that Apple made changes to the heart rate algorithm
that made it effectively impossible for third parties to inform a user
when to take an ECG," or electrocardiogram, White wrote. "Plaintiff's
allegations plausibly establish that Apple's conduct was
anticompetitive."
White also dismissed AliveCor's separate claim that Apple maintained an
illegal monopoly over ECG-capable smart watches.
The Oakland, California-based judge said this was because AliveCor's
KardiaBand wristband, which can record ECGs, "complements but does not
compete" in that market.
[to top of second column]
|
A customer browses Apple watches at the new Apple Store on Broadway
in downtown Los Angeles, California, U.S., June 24, 2021.
REUTERS/Lucy Nicholson
Apple and its lawyers did not
immediately respond to requests for comment. Adam Wolfson, a lawyer
for AliveCor, declined to comment.
In its May 2021 lawsuit, privately held AliveCor accused Apple of
changing the heart rate algorithm for the Apple Watch to gain an
"unfair competitive edge" over rivals, and "put countless AliveCor
users' lives in danger."
Apple, based in Cupertino, California, countered that it was an
"uncontroversial proposition that product improvement by itself" did
not violate the federal Sherman antitrust law.
The case is AliveCor Inc v Apple Inc, U.S. District Court, Northern
District of California, No. 21-03958.
(Reporting by Jonathan Stempel in New York; Editing by Matthew
Lewis)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |